The role of dendritic cells in the pathogenesis of HIV-1 infection

被引:27
作者
Loré, K
Larsson, M
机构
[1] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
[2] Rockefeller Univ, Cellular Physiol & Immunol Lab, New York, NY 10021 USA
关键词
dendritic cells; HIV-1; infection; pathogenesis; adaptive immunity;
D O I
10.1034/j.1600-0463.2003.11107809.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Dendritic cells are professional antigen-presenting cells required for generation of adaptive immunity. These cells are one of the initial target cells for HIV-1 infection or capture of virions at site of transmission in the mucosa. DCs carrying HIV-1 will migrate to the lymphoid tissue where they can contribute to the dissemination of the virus to adjacent CD4(+) T cells. In addition, HIV-1-exposed DCs may have impaired antigen-presenting capacity resulting in inadequate expansion of HIV-1-specific T cell responses. Here, we review the infection of different subtypes of DCs by HIV-1 and the relevance of these cells in the transmission and establishment of HIV-1 disease. In addition, we discuss the mechanisms through which HIV-1-DC interactions could be exploited to optimise the generation and maintenance of HIV-1-specific T cell immunity.
引用
收藏
页码:776 / 788
页数:13
相关论文
共 132 条
[1]   Downregulation of major histocompatibility class I on human dendritic cells by HIV Nef impairs antigen presentation to HIV-specific CD8+ T lymphocytes [J].
Andrieu, M ;
Chassin, D ;
Desoutter, JF ;
Bouchaert, I ;
Baillet, M ;
Hanau, D ;
Guillet, JG ;
Hosmalin, A .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2001, 17 (14) :1365-1370
[2]   Human immunodeficiency virus-1 entry into purified blood dendritic cells through CC and CXC chemokine coreceptors [J].
Ayehunie, S ;
GarciaZepeda, EA ;
Hoxie, JA ;
Horuk, R ;
Kupper, TS ;
Luster, AD ;
Ruprecht, RM .
BLOOD, 1997, 90 (04) :1379-1386
[3]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[4]   Expression of a functional eotaxin (CC chemokine ligand 11) receptor CCR3 by human dendritic cells [J].
Beaulieu, S ;
Robbiani, DF ;
Du, XX ;
Rodrigues, E ;
Ignatius, R ;
Wei, Y ;
Ponath, P ;
Young, JW ;
Pope, M ;
Steinman, RM ;
Mojsov, S .
JOURNAL OF IMMUNOLOGY, 2002, 169 (06) :2925-2936
[5]   Productive infection of dendritic cells by HIV-1 and their ability to capture virus are mediated through separate pathways [J].
Blauvelt, A ;
Asada, H ;
Saville, MW ;
KlausKovtun, V ;
Altman, DJ ;
Yarchoan, R ;
Katz, SI .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (08) :2043-2053
[6]  
Blauvelt Andrew, 1997, American Journal of Medicine, V102, P16, DOI 10.1016/S0002-9343(97)00055-7
[7]   Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo [J].
Boczkowski, D ;
Nair, SK ;
Snyder, D ;
Gilboa, E .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :465-472
[8]   VIRUS-SPECIFIC CD8+ CYTOTOXIC T-LYMPHOCYTE ACTIVITY ASSOCIATED WITH CONTROL OF VIREMIA IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
BORROW, P ;
LEWICKI, H ;
HAHN, BH ;
SHAW, GM ;
OLDSTONE, MBA .
JOURNAL OF VIROLOGY, 1994, 68 (09) :6103-6110
[9]   LATENT INFECTION OF EPIDERMAL LANGERHANS CELLS IN HIV-POSITIVE INDIVIDUALS [J].
BRAATHEN, LR ;
RAMIREZ, G ;
KUNZE, ROF ;
MORK, C ;
STRAND, O .
RESEARCH IN VIROLOGY, 1991, 142 (2-3) :119-121
[10]   MHC-I-restricted presentation of HIV-1 virion antigens without viral replication [J].
Buseyne, F ;
Le Gall, S ;
Boccaccio, C ;
Abastado, JP ;
Lifson, JD ;
Arthur, LO ;
Rivière, Y ;
Heard, JM ;
Schwartz, O .
NATURE MEDICINE, 2001, 7 (03) :344-349